Detalhe da pesquisa
1.
Variations in attitudes towards stereotactic biopsy of adult diffuse midline glioma patients: a survey of members of the AANS/CNS Tumor Section.
J Neurooncol
; 149(1): 161-170, 2020 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-32705457
2.
Clinical presentation and outcomes for adult ependymoma patients.
Cancer
; 123(3): 494-501, 2017 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27679985
3.
Significant predictors of patients' uncertainty in primary brain tumors.
J Neurooncol
; 122(3): 507-15, 2015 May.
Artigo
Inglês
| MEDLINE | ID: mdl-25805495
4.
Uncertainty, mood states, and symptom distress in patients with primary brain tumors: analysis of a conceptual model using structural equation modeling.
Cancer
; 119(15): 2796-806, 2013 Aug 01.
Artigo
Inglês
| MEDLINE | ID: mdl-23661311
5.
Feasibility and preliminary efficacy of a virtual reality intervention targeting distress and anxiety in primary brain tumor patients at the time of clinical evaluation: Study protocol for a phase 2 clinical trial.
Res Sq
; 2023 Feb 16.
Artigo
Inglês
| MEDLINE | ID: mdl-36865245
6.
Relationship between RANO-PRO Working Group standardised priority constructs and disease progression among malignant glioma patients: A retrospective cohort study.
EClinicalMedicine
; 55: 101718, 2023 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-36386035
7.
Feasibility of a virtual reality intervention targeting distress and anxiety symptoms in patients with primary brain tumors: Interim analysis of a phase 2 clinical trial.
Res Sq
; 2023 Jan 31.
Artigo
Inglês
| MEDLINE | ID: mdl-36789426
8.
Validation of the Mishel's uncertainty in illness scale-brain tumor form (MUIS-BT).
J Neurooncol
; 110(2): 293-300, 2012 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-22965831
9.
Assessing mobility in primary brain tumor patients: A descriptive feasibility study using two established mobility tests.
Neurooncol Pract
; 9(3): 219-228, 2022 May.
Artigo
Inglês
| MEDLINE | ID: mdl-35601968
10.
Exploring the prevalence and burden of sleep disturbance in primary brain tumor patients.
Neurooncol Pract
; 9(6): 526-535, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-36388423
11.
The state of neuro-oncology during the COVID-19 pandemic: a worldwide assessment.
Neurooncol Adv
; 3(1): vdab035, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34007966
12.
Identifying symptom recurrences in primary brain tumor patients using the MDASI-BT and qualitative interviews.
J Patient Rep Outcomes
; 3(1): 58, 2019 Aug 23.
Artigo
Inglês
| MEDLINE | ID: mdl-31444579
13.
Relationship between symptom burden and health status: analysis of the MDASI-BT and EQ-5D.
Neurooncol Pract
; 5(1): 56-63, 2018 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-31385972
14.
Survivorship care planning in neuro-oncology.
Neurooncol Pract
; 5(1): 3-9, 2018 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-31386011
15.
Association of genetic variants with fatigue in patients with malignant glioma.
Neurooncol Pract
; 5(2): 122-128, 2018 May.
Artigo
Inglês
| MEDLINE | ID: mdl-31386001
16.
The symptom burden of primary brain tumors: evidence for a core set of tumor- and treatment-related symptoms.
Neuro Oncol
; 18(2): 252-60, 2016 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-26289592
17.
Hope and mood changes throughout the primary brain tumor illness trajectory.
Neuro Oncol
; 18(1): 119-25, 2016 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-26109686
18.
The relationship between corticosteroids and symptoms in patients with primary brain tumors: utility of the Dexamethasone Symptom Questionnaire-Chronic.
Neuro Oncol
; 17(8): 1114-20, 2015 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-25862766
19.
Personal health records, symptoms, uncertainty, and mood in brain tumor patients.
Neurooncol Pract
; 1(2): 64-70, 2014 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-26034618